Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226 014, India.
Indian J Gastroenterol. 2024 Oct;43(5):927-942. doi: 10.1007/s12664-024-01681-4. Epub 2024 Oct 1.
Endoscopic ultrasound (EUS) has evolved from a diagnostic to an interventional modality, allowing precise vascular access and therapy. EUS-guided vascular access of the portal vein has received increasing attention in recent years as a diagnostic and therapeutic tool. EUS-guided portal pressure gradient directly measures the hepatic vein portal pressure gradient and is crucial for understanding of liver function and prognostication of liver disease. EUS facilitates the sampling of portal venous blood to obtain circulating tumor cells (CTCs) in pancreatobiliary malignancies. This technique aids in the diagnosis and staging of cancers. EUS-guided interventions have a substantial potential for diagnosing portal vein tumor thrombus (PVTT) in patients with hepatocellular carcinoma. EUS-guided coil and glue embolization have higher efficacy for the treatment of gastric varices than direct endoscopic glue. Pseudoaneurysm (PsA), a rare vascular complication of acute and chronic pancreatitis, is typically managed with interventional radiology (IR)-guided embolization and surgery. EUS is increasingly used in specialized centers for non-variceal gastrointestinal bleeding, particularly for pseudoaneurysm-related bleeding. There is limited data on EUS-guided intervention for bleeding ectopic varices, rectal varices and Dieulafoy lesions, but it is becoming more widely accepted. In this extensive review, we evaluated both current and potential future applications of EUS-guided vascular interventions, including EUS-guided gastric variceal bleed therapy, rectal and ectopic varices, pseudoaneurysmal bleeding, splenic artery embolization, portal pressure gradient measurement, portal vein sampling for CTCs, fine needle aspiration of PVTT, intrahepatic portosystemic shunt placement, liver tumor ablation and EUS-guided cardiac intervention.
内镜超声(EUS)已经从诊断手段发展为介入手段,能够实现精确的血管入路和治疗。近年来,EUS 引导的门静脉血管入路作为一种诊断和治疗工具受到了越来越多的关注。EUS 引导的门静脉压力梯度直接测量肝静脉门静脉压力梯度,对于了解肝功能和预测肝病的预后至关重要。EUS 有助于对胰胆恶性肿瘤进行门静脉血样采集,以获取循环肿瘤细胞(CTCs)。这项技术有助于癌症的诊断和分期。EUS 引导的介入治疗在诊断肝细胞癌患者门静脉癌栓(PVTT)方面具有很大的潜力。EUS 引导的线圈和胶栓塞治疗胃静脉曲张的疗效优于直接内镜胶栓塞。假性动脉瘤(PsA)是急性和慢性胰腺炎的一种罕见血管并发症,通常采用介入放射学(IR)引导的栓塞和手术治疗。EUS 在专门中心越来越多地用于非静脉曲张性胃肠道出血,特别是与假性动脉瘤相关的出血。关于 EUS 引导的介入治疗异位静脉曲张、直肠静脉曲张和 Dieulafoy 病变出血的数据有限,但它越来越被广泛接受。在这项广泛的综述中,我们评估了 EUS 引导的血管介入治疗的当前和潜在的未来应用,包括 EUS 引导的胃静脉曲张出血治疗、直肠和异位静脉曲张、假性动脉瘤出血、脾动脉栓塞、门静脉压力梯度测量、门静脉血样采集以获取 CTCs、PVTT 的细针穿刺、肝内门体分流术、肝脏肿瘤消融和 EUS 引导的心脏介入。